| Financial Year |
March 31 2023 |
| Monetary Funds |
566,234,057.69 |
| Held-for-trading Financial Assets |
7,058,663.50 |
| Notes Receivable |
-- |
| Accounts Receivable |
61,117,289.11 |
| Advances to Suppliers |
102,128,255.31 |
| Other Receivables |
118,836,757.63 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
774,652,788.28 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
79,097,683.50 |
| Total Current Assets |
1,709,125,495.02 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
42,649,900.42 |
| Investment Properties |
213,892,186.61 |
| Fixed Assetes |
1,811,145,875.29 |
| Under-construction Projects |
13,951,012.35 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
26,966,238.32 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
718,896,207.82 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,925,000.00 |
| Deferred Income Tax Assets |
3,002,119.22 |
| Other Non-Current Assets |
2,496,533.87 |
| Sub-Total of Non-Current Assets |
3,143,699,598.41 |
| Total Assets |
4,852,825,093.43 |
| Short-Term Loans |
559,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
10,000,000.00 |
| Accounts Payable |
214,367,186.82 |
| Accounts Received In Advance |
4,039,370.68 |
| Employee Compensation Payable |
19,068,588.16 |
| Taxes Payable |
70,958,720.59 |
| Interest Payable |
-- |
| Dividend Payable |
473,309.97 |
| Other payables |
217,091,918.05 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
80,159,209.53 |
| Other Current Liabilities |
10,124,545.62 |
| Sub-Total of Current Liabilities |
1,291,579,495.08 |
| Long-term Loans |
309,260,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
15,366,375.54 |
| Other Non-Current Liabilities |
4,339,701.36 |
| Sub-Total of Non-Current Liabilities |
405,809,446.09 |
| Total Liabilities |
1,697,388,941.17 |
| Paid-In Capital(Or Share Stock) |
1,617,142,180.00 |
| Capital Surplus |
107,210,771.89 |
| Surplus Reserve |
255,068,142.39 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,125,805,135.67 |
| Minority Stockholder's Interest |
64,173,182.49 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,091,262,969.77 |
| Owner's Equity（Stockholder's Equity） |
3,155,436,152.26 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,852,825,093.43 |
